Home
overview

The conference listed on this page was held in 2007. For information on the 2010 conference go to www.smi-online.co.uk/2010europricing.asp  

European Pharmaceutical Pricing & Reimbursement Conference 2010

  


With the continued growth of the European Union combined with an ever-increasing desire to move towards an EU single market, the SMi Group’s 13th Annual Pharmaceutical Pricing and Reimbursement could not come at a more crucial time within the industry.
Senior figures from key pharma companies combined with payers and specific country and EU representatives will come together for your benefit to deliver presentations on such vital topics as the future for Pricing and Reimbursement in the European Union and the role Parallel Trade will play within this ever-changing Union.
Your attendance is a must if you wish to remain up to date with this most complex of markets.

6 KEY BENEFITS OF ATTENDING;

1. HEAR UNRIVALLED FORECASTS for the future of Pricing and Reimbursement in the EU
2. DISCOVER if we really are heading towards an EU Single Market
3. LEARN FROM SPECIFIC CASE STUDIES on Pricing and Reimbursement in Germany, Spain, France, Hungary, Romania, Central Europe, the Balkans and more
4. UNDERSTAND how to create pricing dossiers that address the needs of Health Technology    Groups
5. GAIN INSIGHTS INTO the payers perspective on European Pricing and Reimbursement
6. BE AWARE OF HOW Parallel Trade has changed since the accession

NEW CONFIRMED SPEAKER:

Jonathan Galduf, Senior Manager, Amgen (Spain)

CONFIRMED SPEAKERS INCLUDE;
   
KEYNOTE ADDRESS- Andrea Rappagliosi, Vice President, Health Policy and Market Access, Merck Serono and Member, EU High Level Pharmaceutical Forum

  • W. Neil Palmer, Vice President, Pricing & Reimbursement, RTI Health Solutions
  • Luis González Vaqué, Advisor, European Commission
  • Tim Wilsdon, Vice President, CRA International
  • Slawomir Chomik, Area Director, Central Europe, Solvay
  • Oliver Schwerdt, Global Pricing, Bayer Healthcare
  • Aurora Dragomiristeanu, Chief Medical Officer, National Health Insurance House, Romania
  • Tomasz Dzitko, President, Delfarma
  • Dr Boyan Doganov, Director, International Projects, The International Healthcare and Health Insurance Research Institute and Senior Consultant, Mediconsult Group of Companies, Bulgaria


LAST YEAR’S DELEGATES INCLUDED REPRESENTATIVES FROM THE FOLLOWING ORGANISATIONS;

  • Bayer
  • Eli Lilly
  • Schering
  • Merz
  • Astellas
  • GlaxoWellcome
  • Grunenthal
  • Baxter
  • A L T A N A
  • Janssen-Cilag
  • Ministry of Public Health Bucharest
  • Health Insurance House
  • The Association of Pharmaceutical Wholesalers and Importers

THIS EVENT IS AIMED AT THOSE WITH THE FOLLOWING JOB FUNCTIONS, INCLUDING;

Chief Executive/Financial Officers
Global Pricing Vice Presidents/Directors
Pricing Policy Vice Presidents/Directors
Finance Vice Presidents/Directors
Purchasing Vice Presidents/Directors
Reimbursement Vice Presidents/Directors
Health Economics Vice Presidents/Directors
Senior Economists

Conference programme

8:30 Registration & Coffee

9:00 Chairman's Opening Remarks

Neil Palmer

Neil Palmer, Vice President, Pricing & Reimbursement, RTI Health Solutions

9:10 THE FUTURE FOR PRICING & REIMBURSEMENT IN THE EUROPEAN UNION

Luis  González Vaqué

Luis González Vaqué, Advisor, European Commission

·         The European Single Market

·         Parallel Trade: past and future

·         EC Law: Outlining the future

·         Cost versus clinical effectiveness

9:50 PRICING STRATEGY FOR INNOVATIVE AND EXPENSIVE PRODUCTS

Tim Wilsdon

Tim Wilsdon, Vice President, CRA International

  • Optimal product positioning
  • Channel implications
  • Anticipating reaction to indication and population extensions
  • Contract strategies in the context of an expensive product

10:30 Morning Coffee

11:00 PARALLEL TRADE IN THE EU- SEPARATING FACTS FROM FICTION

Tomasz Dzitko

Tomasz Dzitko, President, Delfarma

·         European commission perspective

·         Position of the EFPIA, EAEPC and the Regulators

·         Benefits to payers and patients

·         No market disruption

·         Security for patients

·         No entry of counterfeited products

·         Case Study: Poland, Parallel Trade directions

11:40 PRICING & REIMBURSEMENT IN FRANCE: RECENT TRENDS

Alain Vernot

Alain Vernot, President, APM International

·         Prominent decisions over the last few months

·         Cutting drug costs in hospitals

·         Could medical education help release the grip of the payors?

12:20 Networking Lunch

13:50 IDENTIFYING SUSTAINABLE PHARMACEUTICAL PRICING STRATEGIES AND UTILIZING THEM TO PRACTICAL NEEDS

Oliver Schwerdt

Oliver Schwerdt, Global Pricing, Bayer Schering Pharma AG

  • Balancing Harmony and Reality - the Pricing Environment within the EU
  • The economics of parallel trade as a consequence of EU market environment
  • Tactical measures towards parallel trade implemented by the industry in the past and their results
  • Identifying intelligent long-term pricing strategies
  • Pricing and reimbursement workflows in practice
  • 14:30 CREATING A PRICING DOSSIER THAT ADDRESSES THE NEEDS OF HEALTH TECHNOLOGY GROUPS

    Brian Lovatt

    Brian Lovatt, Chief Executive Officer & Managing Director, Vision Healthcare Research

    ·         Which HTA needs are critical and which are nice to have

    ·         The role of an expert report

    ·         The dossier as part of the pricing strategy

    ·         Using the dossier as the core element of the communication strategy

    15:10 Afternoon Tea

    15:40 PRICING & REIMBURSEMENT AND MARKET ACCESS IN THE UK

    Jim Furniss

    Jim Furniss, Director, Pricing & Reimbursement, Bridgehead International

    ·         Evolution of HTAs and implications

    ·         OFT Report- value based pricing

    ·         Industry outlook

    16:20 PARALLEL IMPORTS AND REPACKAGING

    Dr Duncan Curley

    Dr Duncan Curley, Director, Innovate Legal

    ·         The impact of parallel trade

    ·         Over-stickering and re-boxing- how does the law stand?

    ·         Examples from the caselaw

    ·         Latest competition law developments

    17:00 Chairman’s Closing Remarks and Close of Day One

    8:30 Registration & Coffee

    9:00 Chairman's Opening Remarks

    Alain Vernot

    Alain Vernot, President, APM International

    9:10 EU COMMISSION HIGH LEVEL PHARMACEUTICAL FORUM: ARE WE MOVING TOWARDS AN EU SINGLE MARKET?

    Andrea Rappagliosi

    Andrea Rappagliosi, Vice President, Health Policy and Market Access, Merck-Serono

    ·         Identifying medicines that bring the greatest benefit to patients by ensuring early access to these medicines

    ·         Working towards the goal of achieving the G10 recommendations towards Public Health objectives of offering European citizens an equal access to medicines at an affordable overall cost

    ·         Supplementing the key role of health professionals by improving the quality of and access to information on authorised medicines and related health areas to European patients.

    9:50 PRICING & REIMBURSEMENT IN THE US & CANADA: IMPLICATIONS FOR EUROPE

    Neil Palmer

    Neil Palmer, Vice President, Pricing & Reimbursement, RTI Health Solutions

    ·         United States: Medicare Part D, Medicaid and Managed care

    ·         Canada: Price regulation (PMPRB) & Common Drug Review

    ·         Update on cross border trade & re-importation

    ·         HTA: International cooperation and coordination?

    ·         Medicare price transparency: implications for Euro markets

    ·         North America versus European price trends

    10:30 Morning Coffee

    11:00 PRICING & REIMBURSEMENT IN SPAIN

    Jonathan Galduf

    Jonathan Galduf, Senior Manager, Amgen SA

    ·         The new medicines act- new ideas?

    ·         Use of HTA in Spain- any progress?

    ·         The role of the regions in pharmaceutical policy- any significant impact?

    ·         Future P & R scenarios in Spain

    11:40 PRICING & REIMBURSEMENT IN ROMANIA SINCE THE ACCESSION

    Aurora Dragomiristeanu

    Aurora Dragomiristeanu, Hospital Sales Manager, Europharm Holding, National Health Insurance House

    ·         An update of the current Pricing & Reimbursement situation

    ·         What has changed in Romania since July 2007?

    ·         Drug policy strategy in Romania

    ·         Structure of the pharmaceutical market

    ·         Future challenges to the pharmaceutical market

    12:20 Networking Lunch

    13:50 PRICING AND REIMBURSEMENT IN CENTRAL EUROPE- PERSPECTIVE AFTER THE EU ENLARGEMENT

    Slawomir Chomik

    Slawomir Chomik, Regional Manager, Central Europe, Solvay

  • What are the key issues in Pricing & Reimbursement systems in Central Europe (CE) currently?
  • What are the future trends
  • Recent changes in healthcare systems and their impact on the business model
  • Price transparency: implications for the pharmaceutical market
  • 14:30 PRICING & REIMBURSEMENT IN ITALY

    Fabrizio Gianfrate

    Fabrizio Gianfrate, Professor of Health Economics, University of Ferrara

    ·         Effects of  an increased regional control

    ·         Recent changes in pricing policies

    ·         The role of the Italian Medicines Agency

    ·         Price caps and a new reimbursement class for generics

    15:10 Afternoon Tea

    15:40 PRICING STRATEGIES AND METHODS OF RESTRAINING PUBLIC PHARMACEUTICAL EXPENDITURE

    Chris Swann

    Chris Swann, Market Briefings Analyst, Espicom Business Intelligence

    ·         Pharmaceutical market size in 2007 for the UK, Germany, France and Spain

    ·         Public pharmaceutical/ reimbursable product expenditure as a proportion of the total pharmaceutical market

    ·         National pricing strategies and inter-relationships

    ·         Cost-containment methods

    ·         The role of national bodies e.g. NICE, IQWIG etc

    16:20 Chairman’s Closing Remarks and Close of Conference

    +

    Mövenpick Hotel

    Schoeneberger Strasse 3
    Berlin 10963
    Germany

    Mövenpick Hotel

    HOTEL BOOKING FORM

    Title

    SubTitle
    speaker image

    Content


    Title


    Description

    Download


    WHAT IS CPD?

    CPD stands for Continuing Professional Development’. It is essentially a philosophy, which maintains that in order to be effective, learning should be organised and structured. The most common definition is:

    ‘A commitment to structured skills and knowledge enhancement for Personal or Professional competence’

    CPD is a common requirement of individual membership with professional bodies and Institutes. Increasingly, employers also expect their staff to undertake regular CPD activities.

    Undertaken over a period of time, CPD ensures that educational qualifications do not become obsolete, and allows for best practice and professional standards to be upheld.

    CPD can be undertaken through a variety of learning activities including instructor led training courses, seminars and conferences, e:learning modules or structured reading.

    CPD AND PROFESSIONAL INSTITUTES

    There are approximately 470 institutes in the UK across all industry sectors, with a collective membership of circa 4 million professionals, and they all expect their members to undertake CPD.

    For some institutes undertaking CPD is mandatory e.g. accountancy and law, and linked to a licence to practice, for others it’s obligatory. By ensuring that their members undertake CPD, the professional bodies seek to ensure that professional standards, legislative awareness and ethical practices are maintained.

    CPD Schemes often run over the period of a year and the institutes generally provide online tools for their members to record and reflect on their CPD activities.

    TYPICAL CPD SCHEMES AND RECORDING OF CPD (CPD points and hours)

    Professional bodies and Institutes CPD schemes are either structured as ‘Input’ or ‘Output’ based.

    ‘Input’ based schemes list a precise number of CPD hours that individuals must achieve within a given time period. These schemes can also use different ‘currencies’ such as points, merits, units or credits, where an individual must accumulate the number required. These currencies are usually based on time i.e. 1 CPD point = 1 hour of learning.

    ‘Output’ based schemes are learner centred. They require individuals to set learning goals that align to professional competencies, or personal development objectives. These schemes also list different ways to achieve the learning goals e.g. training courses, seminars or e:learning, which enables an individual to complete their CPD through their preferred mode of learning.

    The majority of Input and Output based schemes actively encourage individuals to seek appropriate CPD activities independently.

    As a formal provider of CPD certified activities, SMI Group can provide an indication of the learning benefit gained and the typical completion. However, it is ultimately the responsibility of the delegate to evaluate their learning, and record it correctly in line with their professional body’s or employers requirements.

    GLOBAL CPD

    Increasingly, international and emerging markets are ‘professionalising’ their workforces and looking to the UK to benchmark educational standards. The undertaking of CPD is now increasingly expected of any individual employed within today’s global marketplace.

    CPD Certificates

    We can provide a certificate for all our accredited events. To request a CPD certificate for a conference , workshop, master classes you have attended please email events@smi-online.co.uk

    Event Title

    Headline

    Text
    Read More

    I would like to speak at an event

    I would like to attend an event

    I would like to sponsor/exhibit at an event

    SIGN UP OR LOGIN

    Sign up
    Forgotten Password?

    Contact SMi GROUP LTD

    UK Office
    Opening Hours: 9.00 - 17.30 (local time)
    SMi Group Ltd, 1 Westminster Bridge Road, London, SE1 7XW, United Kingdom
    Tel: +44 (0) 20 7827 6000 Fax: +44 (0) 20 7827 6001
    Website: http://www.smi-online.co.uk Email: events@smi-online.co.uk
    Registered in England No: 3779287 VAT No: GB 976 2951 71




    Forgotten Password

    Please enter the email address you registered with. We will email you a new password.